Reported Aug 11, 2026 · Announced · Updated Sep 17, 2026
Fresenius Kabi recalls Fresenius Kabi Tyenne Injection 400 mg/20 mL vial due to Due to Presence of Glass Particles
Fresenius Kabi
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
What it looks like
Is this the product you have?
- Tyenne
- Injection 400 mg/20 mL vial BrandFresenius Kabi. Drugs
Why it was recalled
Due to Presence of Glass Particles
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Fresenius Kabi recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.